Analytical Data
-
Gene name
C14orf122
- Application
-
Alternative Names
EMC9; C14orf122; FAM158A; CGI-112; ER membrane Protein complex subunit 9; Protein FAM158A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y3B6
-
Expression Region
1-208aa
-
AA Sequence
EMC9; C14orf122; FAM158A; CGI-112; ER membrane Protein complex subunit 9; Protein FAM158A
-
Molecular Weight
23 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C14orf122, also known as C14orf122 protein or C14orf122 gene, is located on chromosome 14 and has gained attention in the field of molecular biology and genetics due to its potential implications in various cellular processes and diseases. Initial studies suggested that C14orf122 may play a role in regulating immune responses, possibly influencing inflammation and autoimmune disorders. Recent research has identified C14orf122 as important in the development of certain cancers and metabolic disorders, underscoring its significance in biomedical research. The gene's protein product, C14orf122, has been linked to key pathways involved in cell proliferation and apoptosis, making it a candidate for therapeutic targeting. Additionally, recombinant forms of the protein have been produced for detailed functional studies, enabling researchers to elucidate its role in cellular mechanisms and explore its potential as a biomarker for disease diagnosis and prognosis. With advancements in genetic engineering and protein expression systems, investigating C14orf122's structure and function has become increasingly feasible, fostering a deeper understanding of its biological roles and paving the way for innovative therapeutic strategies.
